Vanguard reports 0 shares of Inogen in Schedule 13G/A
The Vanguard Group filed Amendment No. 10 to a Schedule 13G/A reporting zero beneficial ownership of Inogen Inc common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 10 to a Schedule 13G/A reporting zero beneficial ownership of Inogen Inc common stock. The filing states an Amount beneficially owned: 0 and Percent of class: 0% as reported in the amendment dated 03/13/2026. The filing explains an internal realignment and disaggregation of Vanguard subsidiaries in accordance with SEC Release No. 34-39538 (January 12, 1998), noting certain subsidiaries now report separate beneficial ownership. The signature on the amendment is dated 03/27/2026 and is signed by Ashley Grim, Head of Global Fund Administration.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does The Vanguard Group report for INGN in this Schedule 13G/A amendment?
Why does Vanguard state separate reporting for subsidiaries in the amendment?
Who signed the Schedule 13G/A amendment for INGN and when?
Does the amendment identify any other person with more than 5% ownership in INGN?
AI-generated analysis. How Rhea-AI works. Not financial advice.